Shanghai, China

Wu Qiu Ye

This inventor holds 1 USPTO granted patent. Top assignee: Yung Shin Pharmaceutical Ind. Co., Ltd.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wu Qiu Ye. Retrieved from https://idiyas.com/inventor/wu-qiu-ye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wu Qiu Ye: Innovator in Pharmaceutical Compounds

Introduction

Wu Qiu Ye is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. His work has led to the creation of a unique patent that showcases his expertise and creativity.

Latest Patents

Wu Qiu Ye holds a patent for 9H-imidazo[1,2-a]purin-9-one compounds. This patent includes fused tri-heterocyclic compounds characterized by specific formulas involving various chemical groups. His invention is a testament to his skill in synthesizing complex chemical structures that may have important applications in medicine.

Career Highlights

Wu Qiu Ye is currently employed at Yung Shin Pharmaceutical Ind. Co., Ltd. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to the advancement of pharmaceutical research and development. His dedication to his work has positioned him as a valuable asset in the industry.

Collaborations

Wu Qiu Ye has collaborated with notable colleagues, including Fang Yu Lee and Fang Chen Lee. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the innovation process.

Conclusion

Wu Qiu Ye is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the industry significantly. His patent and collaborations reflect his commitment to innovation and excellence in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…